Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Michael Bates

OTHER INVESTOR TYPE
1 INVESTMENTS
1 EXITS
Description

Mr. Michael Bates is an Angel Investor. Mr. Bates served as Director at Dextera Surgical. He was an Advisor of ShareVault. He also is an Angel Investor. Bates serves as an Advisor at Pandesa. Most recently, he was Chief Financial Officer for St. Francis Medical Technologies, acquired by Kyphon Inc. in January 2007 for approximately $725 million. In addition to the St. Francis success, he has contributed to successful investor outcomes in his three previous companies. He served as Vice President of Finance and Administration and CFO for Silicon Genetics, acquired by Agilent Technologies; Collagen Aesthetics, Inc., acquired by Inamed Corporation; and Penederm Incorporated, a publicly-traded specialty pharmaceutical company, acquired by Mylan Laboratories. He is a certified public accountant, having begun his career at Deloitte and Touche LLP. He is a graduate of California State University at Hayward and received an MBA in Finance from the University of California at Berkeley.

Primary Investor Type
Angel (individual)

Michael Bates Investments (1)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
000000 00000000000 00000 (00000 Biotechnology Generating Revenue
To view this investor’s complete investment and acquisition history, request access »
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Michael Bates’s full profile, request a free trial.

Michael Bates Exits (1)

Company Name Exit Date Exit Type Exit Size Status Buyers
000000 00000000000 29-Jun-2016 000000000000000000 0000 Completed
  • 00000000 0000000
To view this investor’s complete exits history, request access »

Michael Bates Team (1)

Name Title Deals Funds Boards Office Contact
Info
Michael Bates Angel Investor